Balchem : to Present Second Quarter Financial Results on July 28, 2023
July 14, 2023 at 07:07 am EDT
Share
Home>Our Company>Investor Relations>Balchem to Present Second Quarter Financial Results on July 28, 2023
Balchem to Present Second Quarter Financial Results on July 28, 2023
Posted: July 14, 2023
Join Ted Harris, Chairman of the Board, President and CEO and Martin Bengtsson, CFO on Friday, July 28, 2023, at 11:00 AM Eastern Time (ET) to review second quarter financial results.
We invite you to listen to the conference by calling toll-free 1-877-407-8289 (local dial-in 1-201-689-8341), five minutes prior to the scheduled start time of the conference call. The conference call will be available for replay two hours after the conclusion of the call through end of day Friday, August 11, 2023. To access the replay of the conference call, dial 1-877-660-6853 (local dial-in 1-201-612-7415), and use conference ID #13740082.
View Press Release
Related Resources
Balchem to Present at the Sidoti June 2023 Virtual Small-Cap Conference on June 15, 2023
Balchem Corporation (NASDAQ: BCPC) Chairman, President and Chief Executive Officer Ted Harris and Chief Financial Officer Martin Bengtsson will present …
Balchem Corporation published this content on 14 July 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 July 2023 11:06:09 UTC.
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company's segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. Through Specialty Products, it re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
BALCHEM CORPORATION 
